BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15855637)

  • 1. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
    Howell DC; Johns RH; Lasky JA; Shan B; Scotton CJ; Laurent GJ; Chambers RC
    Am J Pathol; 2005 May; 166(5):1353-65. PubMed ID: 15855637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
    Howell DC; Goldsack NR; Marshall RP; McAnulty RJ; Starke R; Purdy G; Laurent GJ; Chambers RC
    Am J Pathol; 2001 Oct; 159(4):1383-95. PubMed ID: 11583966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the receptor for advanced glycation end-products in lung fibrosis.
    He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
    Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis.
    Howell DC; Laurent GJ; Chambers RC
    Biochem Soc Trans; 2002 Apr; 30(2):211-6. PubMed ID: 12023853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.
    Mercer PF; Johns RH; Scotton CJ; Krupiczojc MA; Königshoff M; Howell DC; McAnulty RJ; Das A; Thorley AJ; Tetley TD; Eickelberg O; Chambers RC
    Am J Respir Crit Care Med; 2009 Mar; 179(5):414-25. PubMed ID: 19060230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis.
    Lasky JA; Ortiz LA; Tonthat B; Hoyle GW; Corti M; Athas G; Lungarella G; Brody A; Friedman M
    Am J Physiol; 1998 Aug; 275(2):L365-71. PubMed ID: 9700098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
    Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
    Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
    Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
    Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin.
    Yamauchi K; Kasuya Y; Kuroda F; Tanaka K; Tsuyusaki J; Ishizaki S; Matsunaga H; Iwamura C; Nakayama T; Tatsumi K
    Respir Res; 2011 Oct; 12(1):131. PubMed ID: 21970554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1.
    Chambers RC; Leoni P; Blanc-Brude OP; Wembridge DE; Laurent GJ
    J Biol Chem; 2000 Nov; 275(45):35584-91. PubMed ID: 10952976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
    Udalov S; Dumitrascu R; Pullamsetti SS; Al-tamari HM; Weissmann N; Ghofrani HA; Guenther A; Voswinckel R; Seeger W; Grimminger F; Schermuly RT
    BMC Pulm Med; 2010 May; 10():26. PubMed ID: 20444277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.